Ironwood Pharmaceuticals Inc’s recently made public that its Chief Executive Officer MCCOURT Thomas A unloaded Company’s shares for reported $7745.0 on May 16 ’25. In the deal valued at $0.58 per share,13,353 shares were sold. As a result of this transaction, MCCOURT Thomas A now holds 1,147,281 shares worth roughly $0.77 million.
Then, Gaskins Tammi L sold 2,563 shares, generating $1,487 in total proceeds. Upon selling the shares at $0.58, the Chief Commercial Officer now owns 242,596 shares.
Before that, MCCOURT Thomas A bought 14,661 shares. Ironwood Pharmaceuticals Inc shares valued at $8,650 were divested by the Officer at a price of $0.59 per share.
Wells Fargo downgraded its Ironwood Pharmaceuticals Inc [IRWD] rating to an Equal weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in mid April from “a Buy” to “a Hold”. Citizens JMP also remained covering IRWD and has decreased its forecast on April 14, 2025 with a “Mkt perform” recommendation from previously “Mkt outperform” rating. Leerink Partners started covering the stock on September 09, 2024. It rated IRWD as “a Market perform”.
Price Performance Review of IRWD
On Monday, Ironwood Pharmaceuticals Inc [NASDAQ:IRWD] saw its stock jump 7.56% to $0.67. Over the last five days, the stock has gained 13.79%. Ironwood Pharmaceuticals Inc shares have fallen nearly -84.95% since the year began. Nevertheless, the stocks have fallen -89.55% over the past one year. While a 52-week high of $7.11 was reached on 01/07/25, a 52-week low of $0.53 was recorded on 05/16/25.
Levels Of Support And Resistance For IRWD Stock
The 24-hour chart illustrates a support level at 0.6221, which if violated will result in even more drops to 0.5773. On the upside, there is a resistance level at 0.7096. A further resistance level may holdings at 0.7523.
